title: Outpatient131I Treatment for a Patient with Graves' Disease Receiving Hemodialysis.
abstract: A patient presented with hyperthyroidism and end-stage renal disease requiring hemodialysis that was difficult to control despite increased dosages of anti-thyroid drugs. The condition could finally be controlled by131I radioactive iodine therapy (RIT) and hemodialysis provided under a hospital-linkage system. During three hemodialysis sessions after the oral administration of131I, we measured the radioactivity released from the patient and the radioactivity of the devices/tools used. The radioactivity of the devices/tools was managed by allowing the isotope to decay into non-radioactive elements. Our experience suggests that outpatient RIT may provide a safe and convenient means of treating Graves' disease, even in patients receiving hemodialysis.
authors.affiliation: Ito Hospital, Japan.
authors.forename: Miho
authors.initials: M
authors.lastname: Suzuki
authors.forename: Jaeduk
authors.initials: J
authors.lastname: Yoshimura Noh
authors.forename: Kiminori
authors.initials: K
authors.lastname: Sugino
authors.forename: Koichi
authors.initials: K
authors.lastname: Ito
mesh_terms: D000328:Adult; D000553:Ambulatory Care; D013956:Antithyroid Agents / Q000627:therapeutic use; D006111:Graves Disease / Q000150:complications / Q000188:drug therapy / Q000532:radiotherapy*; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008297:Male; D006435:Renal Dialysis
chemical_list: D013956:Antithyroid Agents; D007457:Iodine Radioisotopes